Evidence map›Paper›PMID 22369755›Full record

ArticleLife sciences2012

Reciprocal effects of NNK and SLURP-1 on oncogene expression in target epithelial cells.

Mina Kalantari-Dehaghi, Hans-Ulrich Bernard, Sergei A Grando

Abstract read
In one paragraph

Article in Life sciences, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mina Kalantari-DehaghiDepartment of Dermatology, University of California, Irvine, CA 92697, USA.
Hans-Ulrich Bernard
Sergei A Grando
University of California, Irvine · US

Funding

Epithelial Acetylcholine Oral Biology and PathologyR01DE014173 · NIDCR · UNIVERSITY OF CALIFORNIA-IRVINE · PI GRANDO, SERGEI A · 2002 to 2012
$3.1M
Nicotinic Receptor Ligands and Tobacco-induced Lung CancerR01ES017009 · NIEHS · UNIVERSITY OF CALIFORNIA-IRVINE · PI GRANDO, SERGEI A · 2010 to 2014
$1.7M
NIDCR NIH HHS DE14173NIDCR NIH HHS R01 DE014173NIEHS NIH HHS ES017009NIEHS NIH HHS R01 ES017009
6 · The paper itself

Abstract

aimsTo elucidate how the nicotinic acetylcholine receptors expressed on bronchial and oral epithelial cells targeted by the tobacco nitrosamine (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone) (NNK) facilitate carcinogenic transformation. MAIN

methodsSince NNK-dependent transformation can be abolished by the nicotinergic secreted mammalian Ly-6/urokinase plasminogen activator receptor related protein-1 (SLURP-1), we compared effects of NNK and recombinant (r)SLURP-1 on the expression of genes related to tumorigenesis in human immortalized bronchial and oral epithelial cell lines BEP2D and Het-1A, respectively. KEY

findingsNNK stimulated expression of oncogenic genes, including MYB and PIK3CA in BEP2D, ETS1, NRAS and SRC in Het-1A, and AKT1, KIT and RB1 in both cell types, which could be abolished in the presence of rSLURP-1. Other cancer-related genes whose upregulation by NNK was abolishable by rSLURP-1 were the growth factors EGF in BEP2D cells and HGF in Het-1A cells, and the transcription factors CDKN2A and STAT3 (Het-1A only). NNK also upregulated the anti-apoptotic BCL2 (Het-1A) and downregulated the pro-apoptotic TNF (Het-1A), BAX and CASP8 (BEP2D), all of which could be abolished, in part, by rSLURP-1. NNK decreased expression of the CTNNB1 gene encoding the intercellular adhesion molecule β-catenin (BEP2D), as well as tumor suppressors CDKN3 and FOXD3 in BEP2D cells and SERPINB5 in Het-1A cells. These pro-oncogenic effects of NNK were abolished by rSLURP-1 that also upregulated RUNX3. SIGNIFICANCE: The obtained results identified target genes for both NNK and SLURP-1 and shed light on the molecular mechanism of their reciprocal effects on tumorigenic transformation of bronchial and oral epithelial cells.

Indexed as

Gene Expression Regulation, NeoplasticAntigens, LyBronchiCarcinogensCell Line, TumorCell Transformation, NeoplasticEpithelial CellsHumansLung NeoplasmsMouthMouth NeoplasmsNitrosaminesUrokinase-Type Plasminogen Activator4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanoneAntigens, LyCarcinogensNitrosaminesSLURP1 protein, humanUrokinase-Type Plasminogen Activator

Identifiers

PMID22369755
PMCPMC3371149
OpenAlexW2004035798

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.